PT UBC Medical Indonesia Tbk (ISX:LABS) Notes Receivable: Rp0.00 Mil (As of . 20)


What is PT UBC Medical Indonesia Tbk Notes Receivable?

PT UBC Medical Indonesia Tbk ISX:LABS +2.07% Notes Receivable is Rp0.00 Mil as of . 20. The stock has 2 warning signs investors should review.

PT UBC Medical Indonesia Tbk's Notes Receivable for the quarter that ended in . 20 was Rp0.00 Mil.

PT UBC Medical Indonesia Tbk Notes Receivable Related Terms

PT UBC Medical Indonesia Tbk Notes Receivable Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk Notes Receivable Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
Notes Receivable

PT UBC Medical Indonesia Tbk Semi-Annual Data
Notes Receivable

PT UBC Medical Indonesia Tbk Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of Rp0.00 Mil mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Notes Receivable of Rp0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's Notes Receivable too high?
PT UBC Medical Indonesia Tbk's current Notes Receivable is Rp0.00 Mil.
How does PT UBC Medical Indonesia Tbk's Notes Receivable compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's Notes Receivable of Rp0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current Notes Receivable is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Notes Receivable of Rp0.00 Mil. The current Notes Receivable is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Notes Receivable is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.